Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

5.90
Delayed Data
As of Dec 09
 -0.35 / -5.60%
Today’s Change
5.20
Today|||52-Week Range
10.32
-39.80%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close6.25
Today’s open6.35
Day’s range5.80 - 6.40
Volume60,138
Average volume (3 months)36,318
Market cap$134.3M
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-52.78%
Earnings growth (next 5 years)+13.28%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd+0.04+0.80%
ADVMAdverum Biotechnolog...0.000.00%
AXSMAxsome Therapeutics ...-0.10-1.47%
VBLTVascular Biogenics L...0.000.00%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts


Search for Jobs